Private equity firms Warburg Pincus, EQT AB, and KKR are among potential buyers evaluating a takeover of Gerresheimer, the German medical packaging company, according to a Bloomberg report.
The company confirmed it is in early-stage discussions with private equity investors but emphasized that there is no certainty a public takeover offer will materialize.
Following reports that Gerresheimer is working with advisers to assess interest from suitors, its shares surged as much as 15%. The company stated that it would carefully evaluate any proposals in the best interest of its stakeholders.
The growing interest from private equity firms comes months after activist investor Ricky Chad Sandler acquired a 5.43% stake in Gerresheimer in October 2024, suggesting increased shareholder focus on strategic shifts. While discussions remain preliminary, the involvement of major buyout firms highlights Gerresheimer’s appeal in the medical packaging sector.
Source: Reuters
Can’t stop reading? Read more
Ares raises $5.4bn for US and Europe real estate strategies as recovery drives demand
Ares raises $5.4bn for US and Europe real estate strategies as recovery drives demand Ares has...
Blue Owl caps fund withdrawals as private credit demand recalibrates amid market volatility
Blue Owl caps fund withdrawals as private credit demand recalibrates amid market volatility Blue...
Sycamore targets $4bn profit at Walgreens following $10bn buyout
Sycamore targets $4bn profit at Walgreens following $10bn buyout Sycamore Partners is targeting a...




